Issue navigation
Volume 79, Issue 12, December 2024
Reviews
Machine learning for adverse event prediction in outpatient parenteral antimicrobial therapy: a scoping review
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3055–3062, https://doi.org/10.1093/jac/dkae340
Identifying AWaRe indicators for appropriate antibiotic use: a narrative review
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3063–3077, https://doi.org/10.1093/jac/dkae370
Systematic Reviews
Therapeutic drug monitoring-guided piperacillin dosing in critically ill patients undergoing continuous renal replacement therapy: a systematic review
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3078–3090, https://doi.org/10.1093/jac/dkae332
Systematic review on oral antibacterial relay therapy for acute staphylococcal prosthetic joint infections treated with debridement, antibiotics and implant retention (DAIR)
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3091–3099, https://doi.org/10.1093/jac/dkae347
Original Research
A loading dose of clofazimine to rapidly achieve steady-state-like concentrations in patients with nontuberculous mycobacterial disease
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3100–3108, https://doi.org/10.1093/jac/dkae309
Efficacy and safety of co-trimoxazole in device-related bone and joint infections: a CRIOGO multicentre case–control study
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3109–3115, https://doi.org/10.1093/jac/dkae328
Cefepime–taniborbactam activity against antimicrobial-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa: GEARS global surveillance programme 2018–22
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3116–3131, https://doi.org/10.1093/jac/dkae329
Multicentre evaluation of in vitro activity of contezolid against drug-resistant Staphylococcus and Enterococcus
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3132–3141, https://doi.org/10.1093/jac/dkae331
Quantitative performance of humanized serum and epithelial lining fluid exposures of tigecycline and levofloxacin against a challenge set of Klebsiella pneumoniae and Pseudomonas aeruginosa in a standardized neutropenic murine pneumonia model
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3142–3149, https://doi.org/10.1093/jac/dkae333
Model-based translation of results from in vitro to in vivo experiments for afabicin activity against Staphylococcus aureus
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3150–3159, https://doi.org/10.1093/jac/dkae334
Associations between acquired antimicrobial resistance genes in the upper respiratory tract and livestock farm exposures: a case–control study in COPD and non-COPD individuals
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3160–3168, https://doi.org/10.1093/jac/dkae335
Mycobacterium abscessus strain variability in preclinical drug development: does it really matter?
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3169–3173, https://doi.org/10.1093/jac/dkae336
NDM-5-producing Klebsiella pneumoniae ST258 in a university hospital in Argentina
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3174–3177, https://doi.org/10.1093/jac/dkae337
The efficacy of antimicrobial solutions against multispecies bacterial biofilm with or without negative pressure wound therapy in an in vitro wound model
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3178–3185, https://doi.org/10.1093/jac/dkae338
Genetic and biochemical characterization of OXA-1186, a novel OXA-198-type carbapenemase hydrolysing cephalosporins in Citrobacter freundii
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3186–3190, https://doi.org/10.1093/jac/dkae339
Online availability of antibiotics from within the UK: shifting patterns from 2016 to 2023
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3191–3198, https://doi.org/10.1093/jac/dkae341
poxtA amplification and mutations in 23S rRNA confer enhanced linezolid resistance in Enterococcus faecalis
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3199–3203, https://doi.org/10.1093/jac/dkae342
Amikacin treatment in patients with Enterobacterales bacteraemia: impact of MIC on mortality
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3204–3209, https://doi.org/10.1093/jac/dkae343
Advances in the clinical treatment of multidrug-resistant pathogens using polymyxins
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3210–3229, https://doi.org/10.1093/jac/dkae344
Infective endocarditis caused by penicillin-resistant viridans group streptococci: a series of nine cases from a Spanish cohort
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3230–3235, https://doi.org/10.1093/jac/dkae345
Differential frequency of persister cells in clinically derived isolates of Pseudomonas aeruginosa after exposure to cefiderocol and ceftolozane/tazobactam
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3236–3242, https://doi.org/10.1093/jac/dkae346
Outcomes of patients hospitalized in ward settings for COVID-19 pneumonia with or without early empirical antibiotics
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3243–3247, https://doi.org/10.1093/jac/dkae350
Real-world effectiveness of early anti-SARS therapy in severely immunocompromised COVID-19 outpatients during the SARS-CoV-2 omicron variant era: a propensity score–adjusted retrospective cohort study
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3248–3253, https://doi.org/10.1093/jac/dkae351
The two-component sensor factor envZ influences antibiotic resistance and virulence in the evolutionary dynamics of multidrug-resistant Salmonella enteritidis causing multisite invasive infections
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3254–3263, https://doi.org/10.1093/jac/dkae355
Overall status of carbapenem resistance among clinical isolates of Acinetobacter baumannii: a systematic review and meta-analysis
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3264–3280, https://doi.org/10.1093/jac/dkae358
Target-site cefiderocol pharmacokinetics in soft tissues of healthy volunteers
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3281–3288, https://doi.org/10.1093/jac/dkae359
Impact of discontinuing routine fluoroquinolone prophylaxis in neutropenic allogeneic haematopoietic stem cell transplant recipients: an observational study
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3289–3296, https://doi.org/10.1093/jac/dkae360
Concentrations of ceftazidime and avibactam in bile fluid—a prospective phase IIb study
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3297–3302, https://doi.org/10.1093/jac/dkae361
Population pharmacokinetics/pharmacodynamics of minocycline plus rifampicin in patients with complicated skin and skin structure infections caused by MRSA
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3303–3312, https://doi.org/10.1093/jac/dkae363
Antibiotic biocompatibility assay and anti-biofilm strategies for Pseudomonas aeruginosa infection in bioengineered artificial skin substitutes
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3313–3322, https://doi.org/10.1093/jac/dkae365
Inoculum effect of cefiderocol against NDM-1 producing Escherichia coli in vitro and in a murine model of peritonitis
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3323–3331, https://doi.org/10.1093/jac/dkae368
Ceftriaxone-resistant Neisseria gonorrhoeae detected in England, 2015–24: an observational analysis
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3332–3339, https://doi.org/10.1093/jac/dkae369
Crushed posaconazole delayed-release tablets for antifungal prophylaxis and treatment in children
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3340–3343, https://doi.org/10.1093/jac/dkae373
Identification of vancomycin exposure target in neonates: how much is enough?
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3344–3353, https://doi.org/10.1093/jac/dkae374
Research Letters
A case of lenacapavir use for preventing mother-to-child HIV transmission
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3354–3355, https://doi.org/10.1093/jac/dkae348
Novel optrA-carrying integrative and conjugative element in a porcine Streptococcus suis, Italy
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3356–3358, https://doi.org/10.1093/jac/dkae354
A difficult-to-treat septic arthritis by Scedosporium apiospermum successfully treated with olorofim
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3358–3359, https://doi.org/10.1093/jac/dkae386
Letters to the Editor
Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients—authors’ response
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3360–3361, https://doi.org/10.1093/jac/dkae357
Comment on: Impact of adequate empirical combination therapy on mortality in septic shock due to Pseudomonas aeruginosa bloodstream infections: a multicentre retrospective cohort study
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3361–3362, https://doi.org/10.1093/jac/dkae366
Deleterious effects of a combination therapy using fluoroquinolones and tetracyclines for the treatment of Japanese spotted fever: a retrospective cohort study based on a Japanese hospital database—authors’ response
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3362–3363, https://doi.org/10.1093/jac/dkae378
Acknowledgement of Referees
Acknowledgement of referees
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3364–3369, https://doi.org/10.1093/jac/dkae390
Correction
Correction to: Real-world data on long-acting intramuscular maintenance therapy with cabotegravir and rilpivirine mirror Phase 3 results
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Page 3370, https://doi.org/10.1093/jac/dkae372
